Brain metabolite concentrations are associated with illness severity scores and white matter abnormalities in very preterm infants

Pediatric Research

Volumn 74, Issue 1, 2013, Pages 75-81

  Card, Dallas ^a   Nossin Manor, Revital ^a,b   Moore, Aideen M ^a,c   Raybaud, Charles ^a,d   Sled, John G ^b,d   Taylor, Margot J ^a,b,c,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; CREATINE PHOSPHATE; GLYCEROPHOSPHORYLCHOLINE; LACTIC ACID; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; PHOSPHORYLCHOLINE;

AMINO ACID BRAIN LEVEL; APGAR SCORE; ARTICLE; CLINICAL RISK INDEX FOR BABIES II; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; INFANT; LIPID BRAIN LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLITE; MULTIPLE REGRESSION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEWBORN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; TERM BIRTH; WHITE MATTER LESION;

ASPARTIC ACID; BRAIN; DIPEPTIDES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; SEVERITY OF ILLNESS INDEX;

EID: 84880258766     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.62     Document Type: Article

References (36)

1. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009;8: 110-24.
2. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med 2006;355: 685-94.
3. Miller SP, Ferriero DM, Leonard C, et al. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr 2005;147: 609-16.
4. Volpe JJ. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics 2003;112: 1 Pt 1: 176-80.
5. Spittle AJ, Cheong J, Doyle LW, et al. Neonatal white matter abnormality predicts childhood motor impairment in very preterm children. Dev Med Child Neurol 2011;53: 1000-6.
6. de Bruine FT, van den Berg-Huysmans AA, Leijser LM, et al. Clinical implications of MR imaging findings in the white matter in very preterm infants: a 2-year follow-up study. Radiology 2011;261: 899-906.
7. Miller SP, Ferriero DM. From selective vulnerability to connectivity: insights from newborn brain imaging. Trends Neurosci 2009;32: 496-505.
8. Volpe JJ. Neurology of the Newborn, 5th edn. Philadelphia, PA: Saunder Elsevier, 2008: 415-543.
9. Dezortova M, Hajek M. (1)H MR spectroscopy in pediatrics. Eur J Radiol 2008;67: 240-9.
10. Cecil KM, Jones BV. Magnetic resonance spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001;12: 435-52.
11. Panigrahy A, Borzage M, Bluml S. Basic principles and concepts underlying recent advances in magnetic resonance imaging of the developing brain. Semin Perinatol 2010;34: 3-19.
12. Filippi CG, Ulug AM, Deck MD, Zimmerman RD, Heier LA. Developmental delay in children: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 2002;23: 882-8.
13. Vigneron DB. Magnetic resonance spectroscopic imaging of human brain development. Neuroimaging Clin N Am 2006;16: 75-85, viii.
14. Roelants-van Rijn AM, van der Grond J, Stigter RH, de Vries LS, Groenendaal F. Cerebral structure and metabolism and long-term outcome in small-for-gestational-age preterm neonates. Pediatr Res 2004;56: 285-90.
15. Cady EB, Penrice J, Amess PN, et al. Lactate, N-acetylaspartate, choline and creatine concentrations, and spin-spin relaxation in thalamic and occipito-parietal regions of developing human brain. Magn Reson Med 1996;36: 878-86.
16. Xu D, Bonifacio SL, Charlton NN, et al. MR spectroscopy of normative premature newborns. J Magn Reson Imaging 2011;33: 306-11.
17. Wang ZJ, Vigneron DB, Miller SP, et al. Brain metabolite levels assessed by lactate-edited MR spectroscopy in premature neonates with and without pentobarbital sedation. AJNR Am J Neuroradiol 2008;29: 798-801.
18. Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Huppi PS. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002;48: 949-58.
19. Cheong JL, Cady EB, Penrice J, Wyatt JS, Cox IJ, Robertson NJ. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations. AJNR Am J Neuroradiol 2006;27: 1546-54.
20. Khong PL, Tse C, Wong IY, et al. Diffusion-weighted imaging and proton magnetic resonance spectroscopy in perinatal hypoxic-ischemic encephalopathy: association with neuromotor outcome at 18 months of age. J Child Neurol 2004;19: 872-81.
21. Kadri M, Shu S, Holshouser B, et al. Proton magnetic resonance spectroscopy improves outcome prediction in perinatal CNS insults. J Perinatol 2003;23: 181-5.
22. Zarifi MK, Astrakas LG, Poussaint TY, Plessis AdAd, Zurakowski D, Tzika AA. Prediction of adverse outcome with cerebral lactate level and apparent diffusion coefficient in infants with perinatal asphyxia. Radiology 2002;225: 859-70.
23. Barkovich AJ, Westmark KD, Bedi HS, Partridge JC, Ferriero DM, Vigneron DB. Proton spectroscopy and diffusion imaging on the first day of life after perinatal asphyxia: preliminary report. AJNR Am J Neuroradiol 2001;22: 1786-94.
24. Amess PN, Penrice J, Wylezinska M, et al. Early brain proton magnetic resonance spectroscopy and neonatal neurology related to neurodevelopmental outcome at 1 year in term infants after presumed hypoxic-ischaemic brain injury. Dev Med Child Neurol 1999;41: 436-45.
25. Augustine EM, Spielman DM, Barnes PD, et al. Can magnetic resonance spectroscopy predict neurodevelopmental outcome in very low birth weight preterm infants? J Perinatol 2008;28: 611-8.
26. Robertson NJ, Kuint J, Counsell TJ, et al. Characterization of cerebral white matter damage in preterm infants using 1H and 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab 2000;20: 1446-56.
27. Van Kooij BJM, Benders MJNL, Anbeek P, Van Haastert IC, De Vries LS, Groenendaal F. Cerebellar volume and proton magnetic resonance spectroscopy at term, and neurodevelopment at 2 years of age in preterm infants. Dev Med Child Neurol 2012;54: 260-6.
28. Gadin E, Lobo M, Paul DA, et al. Volumetric MRI and MRS and early motor development of infants born preterm. Pediatr Phys Ther 2012;24: 38-44.
29. Chau V, Poskitt KJ, McFadden DE, et al. Effect of chorioamnionitis on brain development and injury in premature newborns. Ann Neurol 2009;66: 155-64.
30. Chau V, Brant R, Poskitt KJ, Tam EW, Synnes A, Miller SP. Postnatal infection is associated with widespread abnormalities of brain development in premature newborns. Pediatr Res 2012;71: 274-9.
31. Leth H, Toft PB, Pryds O, Peitersen B, Lou HC, Henriksen O. Brain lactate in preterm and growth-retarded neonates. Acta Paediatr 1995;84: 495-9.
32. Dorling JS, Field DJ, Manktelow B. Neonatal disease severity scoring systems. Arch Dis Child Fetal Neonatal Ed 2005;90: F11-6.
33. Xu D, Vigneron D. Magnetic resonance spectroscopy imaging of the newborn brain-a technical review. Semin Perinatol 2010;34: 20-7.
34. Parry G, Tucker J, Tarnow-Mordi W; UK Neonatal Staffing Study Collaborative Group. CRIB II: an update of the clinical risk index for babies score. Lancet 2003;361: 1789-91.
35. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14: 260-4.
36. Provencher SW. LCModel & LCMgui User's Manual. (http://s-provencher. com/pub/LCModel/manual/manual.pdf). Accessed 1 February 2013.